Loading
Latest filing published 19 Dec 2024 for Design Therapeutics, Inc., €23k. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of Deepa Prasad in Design Therapeutics, Inc., where the filings describe the role as board member. We count 3 filings; the first trade dates from 16 March 2022 and the latest from 18 December 2024.
Market trades split into 1 purchase (€25k) and 1 sale (€23k). On balance, insiders were net buyers of €2,719. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2024, the count stands at no purchases and 1 sale.
The record was last updated on 19 December 2024 with an open-market sale (€23k) in Design Therapeutics, Inc. The last purchase on record was published on 30 August 2023, which is 1,145 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations